MDM4 and neoplasm: These results indicate that wild-type p53 upregulation associated with downregulation of MDM2 and MDMX can also play a dominant role in the killing of tumour cells by SF3B1 inhibition and that there may be a level of tumour selectivity because of the greater sensitivity of MDM2/MDMX expression in transformed cells.